New Episode: What a Series investor sees AI Use Differs in the US and China
Our latest podcast guest Ray Yang of Marathon Capital and previously Northern Light Capital shares his key observations about AI health applications in the United States and China, and how a humble Huimingbao is making strides providing much-needed coverage to innovative oncology and CAR-T therapies.
